Citations (0)
Keep up to date with the latest research on this topic with citation updates for this article.
Journal of Asthma and Allergy
Volume 17, 2024 - Issue
REVIEW
Tezepelumab for Severe Asthma: One Drug Targeting Multiple Disease Pathways and Patient Types
Reynold Panettieri Jr1 Rutgers Institute for Translational Medicine and Science, Rutgers University, New Brunswick, NJ, USACorrespondence[email protected]
https://orcid.org/0000-0003-0834-4636View further author information
https://orcid.org/0000-0003-0834-4636View further author information, Njira Lugogo2 Michigan Medicine Asthma Program, University of Michigan, Ann Arbor, MI, USAhttps://orcid.org/0000-0002-0235-7105View further author information
https://orcid.org/0000-0002-0235-7105View further author information, Jonathan Corren3 Departments of Medicine and Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USAhttps://orcid.org/0000-0001-5951-3239View further author information
https://orcid.org/0000-0001-5951-3239View further author information & Christopher S Ambrose4 AstraZeneca, Gaithersburg, MD, USAhttps://orcid.org/0000-0003-4175-7336View further author information
https://orcid.org/0000-0003-4175-7336View further author information